DOCSLIB.ORG

Position Name Institution Rank C Academic Year 1 Mantovani, Alberto Humanitas University 102 47 2 Mancia, Giuseppe University

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Position Name Institution Rank C Academic Year 1 Mantovani, Alberto Humanitas University 102 47 2 Mancia, Giuseppe University Position Name Institution Rank C Academic Year 1 Mantovani, Alberto Humanitas University 102 47 2 Mancia, Giuseppe University of Milano ‐ Bicocca 292 54 3 Mannucci, Pier Mannuccio Ospedale Maggiore Policlinico Milano 477 56 4La Vecchia, C. Università degli Studi di Milano 487 41 5 Remuzzi, Giuseppe Laboratori Negri Bergamo 505 44 6 Barone, Vincenzo Scuola Normale Superiore di Pisa 598 43 7 Zanchetti, Alberto Università degli Studi di Milano 740 69 8 Romagnani, Sergio Università degli Studi di Firenze 768 53 9 Schwartz, Peter J. IRCCS Istituto Auxologico Italiano 935 53 10 Coats, Andrew J.S. IRCCS San Raffaele Pisana 1022 33 11 Ceriello, Antonio IRCCS Multimedica 1061 41 12 Franceschi, Silvia IRCCS Centro Di Riferimento Oncologico Aviano 1283 41 13 Parisi, Giorgio Università degli Studi di Roma La Sapienza 1329 49 14 Rizzolatti, Giacomo Consiglio Nazionale delle Ricerche 1349 56 15 Busca, Guido Università degli Studi di Genova 1400 42 16 Gallese, Vittorio Università degli Studi di Parma 1456 36 17 Ferrannini, Ele Istituto di Fisiologia Clinica del CNR 1551 35 18 Balzani, Vincenzo Alma Mater Studiorum Università di Bologna 1804 55 19 Giorgi, Filippo Abdus Salam International Centre for Theoretical Physics 1806 35 20 Maffulli, Nicola Università di Salerno 2039 33 21 Filippi, Massimo Università Vita‐Salute San Raffaele 2181 32 22 Supuran, Claudiu T. Università degli Studi di Firenze 2205 28 23 Rosai, Juan *Department of Pathology †Internaonal Center for Oncologic Pathology Consultaons 2223 54 24 Shallice, Tim Scuola Internazionale Superiore di Studi Avanzati 2253 56 25 Di Chiara, Gaetano Università degli Studi di Cagliari 2255 49 26 Priori, Silvia G. Università degli Studi di Pavia 2341 35 27 Dejana, Elisabetta Fondazione IFOM Istituto Firc di Oncologia Molecolare 2361 43 28 Gatteschi, Dante Università degli Studi di Firenze 2375 49 29 Tomasi, Jacopo Università di Pisa 2441 56 30 Ribatti, Domenico Università degli Studi di Bari, Facoltà di Medicina e Chirurgia 2445 40 31 Perucca, Emilio Università degli Studi di Pavia 2585 44 32 Naldini, Luigi Università Vita‐Salute San Raffaele 2677 39 33 Ronco, Claudio Ospedale San Bortolo 2699 41 34 Serpone, N. Università degli Studi di Pavia 2700 53 35 Carafoli, Ernesto Venetian Institute of Molecular Medicine 2767 62 36 Antolini, Ermete Scuola di Scienza dei Materiali 3042 31 37 Bernardi, Paolo Università degli Studi di Padova 3054 41 38 Trasatti, Sergio Università degli Studi di Milano 3269 52 39 Bianchi, Giuseppe Università degli Studi di Roma Tor Vergata 3299 43 40 Prandoni, P. Arianna Foundation on Anticoagulation 3328 40 41 Pacchioni, Gianfranco University of Milano ‐ Bicocca 3407 41 42 Zoccali, Carmine Consiglio Nazionale delle Ricerche 3579 46 43 Muzzarelli, Riccardo A.A. Università Politecnica delle Marche 3610 51 44 Patrono, Carlo Università Cattolica del Sacro Cuore, Rome, Facoltà di Medicina e Chirurgia 3618 47 45 Maggi, C. A. A. Menarini Industrie Farmaceutiche Riunite Srl 3657 36 46 Moretta, Alessandro Università degli Studi di Genova 3717 46 47 Comi, Giancarlo IRCCS San Raffaele Scientific Institute 3861 53 48 Colombo, Antonio IRCCS San Raffaele Scientific Institute 3879 44 49 Bianchi, Marco E. Università Vita‐Salute San Raffaele 4028 39 50 De Caterina, Raffaele Università di Pisa 4072 40 51 Sessoli, R. Università degli Studi di Firenze 4275 32 52 Veronesi, Umberto Istituto Europeo di Oncologia 4316 65 53 Carrera, E. Politecnico di Torino 4330 30 54 Chesbrough, Henry Libera Università Internazionale degli Studi Sociali Guido Carli 4361 21 55 Colao, Annamaria Università degli Studi di Napoli Federico II 4419 33 56 Mercadante, S. La Maddalena Cancer Center 4431 37 57 Ferrari, Roberto Maria Cecilia Hospital 4448 44 58 Grant, Robert M. Università Bocconi 4674 34 59 Plebani, Mario Azienda Ospedaliera Di Padova 4703 43 60 Di Virgilio, Francesco University of Ferrara 4799 41 61 Parati, Gianfranco University of Milano ‐ Bicocca 4858 43 62 Grassi, Guido University of Milano ‐ Bicocca 4861 40 63 Cuzzocrea, Salvatore Università degli Studi di Messina 5088 24 64 Raviglione, Mario Università degli Studi di Milano 5130 32 65 Ngai, K. L. Consiglio Nazionale delle Ricerche 5216 43 66 Centi, Gabriele Università degli Studi di Messina 5228 40 67 Montorsi, F. IRCCS San Raffaele Scientific Institute 5269 52 68 Liberati, Alessandro Istituto di Ricerche Farmacologiche Mario Negri 5433 34 69 Bacigalupo, Andrea Fondazione Policlinico Universitàrio Agostino Gemelli IRCCS Università Cattolica del Sacro Cuore 5462 46 70 Cavalli‐Sforza, L. L. Università Vita‐Salute San Raffaele 5624 57 71 Cutolo, M. Università degli Studi di Genova 5651 41 72 Agnelli, Giancarlo Università degli Studi di Perugia 5667 43 73 Romani, Luigina Università degli Studi di Perugia 5814 48 74 Maj, Mario Università degli Studi della Campania Luigi Vanvitelli 6071 41 75 Mennucci, Benedetta Università di Pisa 6084 26 76 Bemporad, Alberto Institutions Markets Technologies, Lucca 6302 26 77 Franchini, Massimo Azienda Ospedaliera Carlo Poma 6460 24 78 Rizzuto, Rosario Università degli Studi di Padova 6560 33 79 De Franchis, Roberto Università degli Studi di Milano 6699 49 80 Verdecchia, Paolo Azienda Ospedaliera di Perugia 6767 40 81 Sandri, Marco Università degli Studi di Padova 6815 29 82 Cattaneo, Marco Università degli Studi di Milano 6854 43 83 Ciardiello, Fortunato Università degli Studi della Campania Luigi Vanvitelli 6859 33 84 Lencioni, Riccardo Università di Pisa 6932 29 85 Ponticelli, Claudio Ospedale Maggiore Policlinico Milano 6942 56 86 Giugliano, Dario Università degli Studi della Campania Luigi Vanvitelli 6956 44 87 Maseri, Attilio Heart Care Foundation 7081 56 88 Targher, Giovanni University and Azienda Ospedaliera Universitària Integrata of Verona 7089 27 89 Makkar, Harinder P.S. Food and Agriculture Organization of the United Nations 7137 39 90 DiFrancesco, Dario Università degli Studi di Milano 7271 42 91 Gavezzotti, Angelo Università degli Studi di Milano 7297 49 92 Marchioli, Roberto IQVIA Inc. 7387 32 93 Blasi, C. Di Università degli Studi di Napoli Federico II 7469 37 94 Tavazzi, Luigi Maria Cecilia Hospital 7476 48 95 Moretta, Lorenzo IRCCS Ospedale Pediatrico Bambino Gesù 7590 46 96 Colombo, Massimo Humanitas Research Hospital 7646 48 97 Pietrangelo, Antonello Università degli Studi di Modena e Reggio Emilia 7736 36 98 Danese, Silvio Humanitas University 7740 35 99 Palatini, P. Università degli Studi di Padova 7807 44 100 Sciortino, Francesco Università degli Studi di Roma La Sapienza 7815 32 101 Stringari, S. Università degli Studi di Trento 7853 44 102 Ferrara, Sergio INFN, Laboratori Nazionali Di Frascati 7974 49 103 Reverchon, Ernesto Università di Salerno 8007 38 104 Viale, Giuseppe Istituto Europeo di Oncologia 8053 68 105 Balducci, Lodovico Fondazione Policlinico Universitàrio Agostino Gemelli IRCCS Università Cattolica del Sacro Cuore 8060 42 106 Comoglio, Paolo Maria Candiolo Cancer Institute‐FPO‐ IRCCS 8250 54 107 Nason, P. Istituto Nazionale di Fisica Nucleare, Sezione di Milano 8253 37 108 Bianco, Paolo Università degli Studi di Roma La Sapienza 8283 35 109 Costa, Lucio G. Università degli Studi di Parma 8293 40 110 Zorzi, Michele Università degli Studi di Padova 8302 28 111 Trovarelli, Alessandro Università degli Studi di Udine 8306 32 112 Cazzola, Mario Università degli Studi di Pavia 8354 46 113 Benedetti, Fabrizio Università degli Studi di Torino, Facoltà di Medicina e Chirurgia 8376 25 114 Capozziello, Salvatore Università degli Studi di Napoli Federico II 8390 28 115 Cinti, Saverio Università Politecnica delle Marche 8504 41 116 Barbui, Tiziano Papa Giovanni XXIII Hospital 8574 52 117 Catani, Stefano Istituto Nazionale di Fisica Nucleare, Sezione di Firenze 8625 36 118 Bonadonna, Gianni Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 8659 52 119 Orban, Guy A. Università degli Studi di Parma 8667 53 120 Braga, Dario Alma Mater Studiorum Università di Bologna 8734 42 121 Dondoni, Alessandro University of Ferrara 8783 54 122 Righetti, Pier Giorgio Politecnico di Milano 8902 50 123 Piepoli, Massimo F. Ospedale Guglielmo da Saliceto 8906 33 124 Guerrini, Renzo Azienda Ospedaliero Universitària Meyer 8955 36 125 Brandi, Maria Luisa Università degli Studi di Firenze 9014 42 126 Rossini, P. M. IRCCS San Raffaele Pisana 9108 44 127 Amelino‐Camelia, Giovanni Università degli Studi di Napoli Federico II 9210 28 128 Argos, Patrick Università degli Studi di Roma La Sapienza 9225 30 129 Parazzini, Fabio Università degli Studi di Milano 9256 64 130 Lippi, Giuseppe Università degli Studi di Verona 9265 30 131 Dosi, Giovanni Scuola Superiore Sant'Anna di Studi Universitàri e di Perfezionamento 9301 39 132 Melino, Gerry Università degli Studi di Roma Tor Vergata 9329 42 133 Pantoni, Leonardo Ospedale Luigi Sacco ‐ Polo Universitàrio 9334 29 134 Ruggenenti, Piero L. Laboratori Negri Bergamo 9356 35 135 Forzatti, Pio Politecnico di Milano 9397 45 136 Montecucco, Cesare Università degli Studi di Padova 9479 45 137 Bonora, Enzo Università degli Studi di Verona 9518 39 138 Pecorelli, Sergio Università degli Studi di Brescia 9593 44 139 Gainotti, Guido IRCCS Fondazione Santa Lucia 9680 68 140 Blasi, Francesco Università degli Studi di Milano 9711 53 141 Zio, Enrico Politecnico di Milano 9756 28 142 Pavesi, Lorenzo Università degli Studi di Trento 9950 33 143 Karimi, Hamid Reza Politecnico di Milano 9953 19 144 Beghi, Ettore Istituto di Ricerche Farmacologiche Mario Negri 9962 38 145 Carattoli, Alessandra Università degli Studi di Roma La Sapienza 9966 31 146 Rizzetto, Mario Università degli Studi di Torino
Load more

Recommended publications
  • Creating Value in the Entrepreneurial University: Marketization and Merchandising Strategies
    administrative sciences Article Creating Value in the Entrepreneurial University: Marketization and Merchandising Strategies Chiara Fantauzzi *, Rocco Frondizi , Nathalie Colasanti and Gloria Fiorani Department of Management and Law, University of Rome Tor Vergata, 00133 Roma, Italy; [email protected] (R.F.); [email protected] (N.C.); gloria.fi[email protected] (G.F.) * Correspondence: [email protected] Received: 9 August 2019; Accepted: 14 October 2019; Published: 18 October 2019 Abstract: Higher education institutions are called to expand their role and responsibilities, by enhancing their entrepreneurial mindset and redefining relationships with stakeholders. In order to cope with these new challenges, they have started to operate in a strategic manner, by performing marketing and merchandising activities. Indeed, in a sector characterized by the presence of competitive funding models, several forms of accountability, and performance indicators, universities have become open systems and have started to operate like enterprises, considering students as customers. Given this premise, the aim of the paper is to individuate marketing and merchandising strategies in higher education and to evaluate their effectiveness in order to foster stakeholders engagement. This is in line with the entrepreneurial university model that represents the starting point of the theoretical study, then a literature review of “marketization” in higher education institutions is presented, showing how this field is not yet completely investigated. Data refer to the Italian context and are analyzed through a qualitative method. Findings suggest that most Italian universities perform merchandising strategies, but currently there is not sufficient information to evaluate their effectiveness in higher education, it was only possible to make hypotheses.
    [Show full text]
  • Unveiling Role of Sphingosine-1-Phosphate Receptor 2 As a Brake of Epithelial Stem Cell Proliferation and a Tumor Suppressor in Colorectal Cancer
    Unveiling role of Sphingosine-1-phosphate receptor 2 as a brake of epithelial stem cell proliferation and a tumor suppressor in colorectal cancer Luciana Petti Humanitas Clinical and Research Center-IRCCS Giulia Rizzo Humanitas University Federica Rubbino Humanitas University Sudharshan Elangovan Humanitas University Piergiuseppe Colombo Humanitas Clinical and Research Center-IRRCS Restelli Silvia Humanitas University Andrea Piontini Humanitas University Vincenzo Arena Policlinico Universitario Agostino Gemelli Michele Carvello Humanitas Clinical and Research Center-IRCCS Barbara Romano Universita degli Studi di Napoli Federico II Dipartimento di Medicina Clinica e Chirurgia Tommaso Cavalleri Humanitas Clinical and Research Center-IRCCS Achille Anselmo Humanitas Clinical and Research Center-IRCCS Federica Ungaro Humanitas University Silvia D’Alessio Humanitas University Antonino Spinelli Humanitas University Sanja Stifter Page 1/28 University of Rijeka Fabio Grizzi Humanitas Clinical and Research Center-IRCCS Alessandro Sgambato Istituto di Ricovero e Cura a Carattere Scientico Centro di Riferimento Oncologico della Basilicata Silvio Danese Humanitas University Luigi Laghi Universita degli Studi di Parma Alberto Malesci Humanitas University STEFANIA VETRANO ( [email protected] ) Humanitas University Research Keywords: colorectal cancer, Lgr5, S1PR2, PTEN, epithelial proliferation Posted Date: October 13th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-56319/v2 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Version of Record: A version of this preprint was published on November 23rd, 2020. See the published version at https://doi.org/10.1186/s13046-020-01740-6. Page 2/28 Abstract Background. Sphingosine-1-phosphate receptor 2 (S1PR2) mediates pleiotropic functions encompassing cell proliferation, survival, and migration, which become collectively de-regulated in cancer.
    [Show full text]
  • BSM School Profile 2020
    The British School of Milan www.britishschoolmilan.com Via Carlo Alberto Pisani Dossi, 16 - 20134 Milan, Italy Telephone: +39 02210941 CEEB Code: 748246 learning to excel since 1969 IB number: 3665 BSM SCHOOL PROFILE 720 3-18 40 100% Students Age Range IB Points Average A*- C IGCSE for Top 20 Students Grades The only school in Milan rated 100 43 “Excellent” by UK Government 50 107 Teachers Nationalities Inspectors Years of World-Class Co-curricular Education Activities Established 1969 Mission Independent, day school IB World School Our mission is to inspire learning within a caring, COBIS and HMC affiliated creative and international community, to pursue excellence, and to challenge students as they Not for Profit prepare for university and the world beyond. Rated One of the Top 10 Schools in Europe Graduating class of Average IB Diploma Score 100% 50 36 Points University Entry Assessment and Gr ading GCSE at age 16 • A* (highest) to G (lowest) • 9 (highest) to 1 (lowest) International Baccalaureate Diploma (IB) at age 18 • 6 subjects 7 (highest) - 1 (lowest) • Up to 3 Core points from Core (4,000-word Extended Essay + Theory of Knowledge) • Creativity, Activity, Service programme • Maximum 45 points The British School of Milan does not compute GPA or provide class ranking. Contact Information Primary Contact for University Enquiries Nicolas Amy Director of Sixth Form and University Counsellor [email protected] Chris Greenhalgh Principal and CEO [email protected] Julie Walker Head of Senior School [email protected]
    [Show full text]
  • Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes
    International Journal of Molecular Sciences Review Heterogeneity of Colorectal Cancer Progression: Molecular Gas and Brakes Federica Gaiani 1,2 , Federica Marchesi 3,4, Francesca Negri 5 , Luana Greco 6, Alberto Malesci 3,7, Gian Luigi de’Angelis 1,2 and Luigi Laghi 1,6,* 1 Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy; [email protected] (F.G.); [email protected] (G.L.d.) 2 Gastroenterology and Endoscopy Unit, University-Hospital of Parma, via Gramsci 14, 43126 Parma, Italy 3 IRCCS Humanitas Research Hospital, via Manzoni 56, 20089 Rozzano, Italy; [email protected] (F.M.); [email protected] (A.M.) 4 Department of Medical Biotechnology and Translational Medicine, University of Milan, 20132 Milan, Italy 5 Medical Oncology Unit, University Hospital of Parma, 43126 Parma, Italy; [email protected] 6 Laboratory of Molecular Gastroenterology, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089 Rozzano, Italy; [email protected] 7 Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072 Pieve Emanuele, Italy * Correspondence: [email protected] Abstract: The review begins with molecular genetics, which hit the field unveiling the involvement of oncogenes and tumor suppressor genes in the pathogenesis of colorectal cancer (CRC) and uncovering genetic predispositions. Then the notion of molecular phenotypes with different clinical behaviors was introduced and translated in the clinical arena, paving the way to next-generation sequencing that captured previously unrecognized heterogeneity. Among other molecular regulators of CRC progression, the extent of host immune response within the tumor micro-environment has a critical Citation: Gaiani, F.; Marchesi, F.; position.
    [Show full text]
  • For Peer Review Only
    BMJ Open BMJ Open: first published as 10.1136/bmjopen-2015-009669 on 31 March 2016. Downloaded from Intravesical administration of combined hyaluronic acid (HA) and chondroitin sulphate (CS) for the treatment of female recurrent urinary tract infections: a European multicenter nested case-control study For peer review only Journal: BMJ Open Manuscript ID: bmjopen-2015-009669 Article Type: Research Date Submitted by the Author: 10-Aug-2015 Complete List of Authors: Ciani, Oriana; University of Exeter , University of Exeter Medical School; CeRGAS Bocconi, Arendsen, Erik; Diaconessenhuis, Dept. of Urology Romancik, Martin; St. Cyril and Method University Hospital, Dept. of Urology Lunik, Richard; Fakultná nemocnica s poliklinikou, Dept. of Urology Costantini, Elisabetta; University of Perugia, Dept. of Surgical and Biomedical Science Di Biase, Manuel; University of Perugia, Dept. of Surgical and Biomedical Science Morgia, Giuseppe; University of Catania, Dept. of Urology http://bmjopen.bmj.com/ Fragala', Eugenia; University of Catania, Dept. of Urology Tomaskin, Roman; Jessenius School of Medicine, Dept. of Urology Bernat, Marian; Fakultná nemocnica s poliklinikou, Dept. of Urology Guazzoni, Giorgio; Humanitas Clinical and Research Center, Dept. of Urology Tarricone, Rosanna; Bocconi University, Dept. of Policy Analysis and Public Management Lazzeri, Massimo; Humanitas Clinical and Research Center, Dept. of Urology on September 29, 2021 by guest. Protected copyright. <b>Primary Subject Urology Heading</b>: Secondary Subject Heading: Infectious diseases Urinary tract infections < UROLOGY, Antimicrobial Resistance, Hyaluronic Keywords: acid, chondroitin sulphate For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml Page 1 of 25 BMJ Open BMJ Open: first published as 10.1136/bmjopen-2015-009669 on 31 March 2016.
    [Show full text]
  • Reviewers 2020
    AP&T Reviewers 2020 Highlighted reviewer denotes a top reviewer for 2020 Reviewer Last Name Reviewer First Name Reviewer Institution Reviewer Country/Region Abdel-Daim Mohamed Suez Canal University Egypt Abergel Armand Hôtel-Dieu France Abraham Neena Mayo Clinic Scottsdale United States Abraldes Juan University of Alberta Canada Afdal Nezam Beth Israel Deaconess Medical Center United States Afolabi Paul University of Soutjampton United Kingdom of Great Britain and Northern Ireland Afzal Nadeem Southampton University Hospital Trust United Kingdom of Great Britain and Northern Ireland Agardh Daniel Pediatrics Epidemiology Center United States Agarwal Banwari Royal Free Hospital United Kingdom of Great Britain and Northern Ireland Agarwal Kosh United Kingdom of Great Britain and Northern Ireland Aggarwal Rakesh Sanjay Gandhi Postgraduate Institute of Medical Sciences India Aghemo Alessio Istituto Clinico Humanitas Italy Agnholt Jørgen Aarhus University Hospital Denmark Ahmad Tariq Royal Devon and Exeter NHS Foundation Trust United Kingdom of Great Britain and Northern Ireland Ahuja Vineet All India Institute of Medical Sciences India Aithal Guruprasad University of Nottingham United Kingdom of Great Britain and Northern Ireland Alazawi William Barts and The London School of Medicine and Dentistry United Kingdom of Great Britain and Northern Ireland Alexopoulou Alexandra Greece Allez Matthieu Hôpital Saint-Louis France Allin Kristine Alpers David Washington Univ School of Medicine United States Amiot Aurélien Henri Mondor University Hospital
    [Show full text]
  • SUPPLEMENTARY APPENDIX Rare Variants Lowering the Levels of Coagulation Factor X Are Protective Against Ischemic Heart Disease
    SUPPLEMENTARY APPENDIX Rare variants lowering the levels of coagulation factor X are protective against ischemic heart disease Elvezia Maria Paraboschi, 1,2 Amit Vikram Khera, 3,4,5 Piera Angelica Merlini, 6 Laura Gigante, 7 Flora Peyvandi, 8,9 Mark Chaffin, 3,4,5 Marzia Menegatti, 8 Fabiana Busti, 10 Domenico Girelli, 10 Nicola Martinelli, 10 Oliviero Olivieri, 10 Sekar Kathiresan, 3,4,5 Diego Ardissino, 7 Rosanna Asselta 1,2 and Stefano Duga 1,2 1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy; 2Humanitas Clinical and Research Center, Rozzano, Italy; 3Cen - ter for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; 4Department of Medicine, Massachusetts General Hospital, Cardiology Division, Harvard Medical School, Boston, MA, USA; 5Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA; 6Division of Cardiology, Azienda Ospedaliera Ospedale Niguarda Cà Granda, Milan, Italy; 7Division of Cardiology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy; 8Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and Luigi Villa Foundation, Milan, Italy; 9Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy and 10 Department of Medicine, Section of Internal Medicine, University of Verona, Verona, Italy Correspondence: ROSANNA ASSELTA - [email protected] doi:10.3324/haematol.2019.237750 SUPPLEMENTARY MATERIAL Rare variants lowering
    [Show full text]
  • Medical School
    Medical School hunimed.eu Why choose and Catania, Italy. IRCCS Istituto Clinico Humanitas is our flagship Humanitas hospital: it is a highly specialised tertiary care hospital and one of University the most technologically advanced in Europe as well as a leading tudying at Humanitas research centre. University means you will have Sday-to-day clinical contact During your study, you will be with both a leading hospital and able to enjoy experiences abroad, group of doctors, researchers, thanks to the Erasmus Programme nurses and other healthcare or specific travel grants. professionals involved in ground- breaking research. All our university courses are built You will also meet up with students on the high- quality teaching and from over 20 countries worldwide; international experience of the over 39% of our medical students Faculty, doctors and researchers. are from abroad. The Student The courses foresee robust Office will assist you even before interaction between students your arrival with the administrative and healthcare professionals as paperwork to be completed in your well as numerous activities where home country. theoretical knowledge is integrated with practical clinical skills. Students The hospital plays an important role also have the opportunity to learn in your clinical training. Humanitas and practise in our state-of-the-art University is closely integrated with Simulation Centre and Anatomy the hospitals of the Group, located Lab. in Milan, Bergamo, Castellanza, Turin Research and organisational model, which blends high-quality clinical practice, economic clinical practice at sustainability, development and social the service of the responsibility. The Research Centre is internationally patient renowned for its research on immune system diseases.
    [Show full text]
  • School Profile
    INTERNATIONAL SCHOOL OF TURIN Our Mission: IST inspires lifelong learning and international mindedness, empowering each student to reach their full potential. IST is a fully authorized IB World School, offering the Primary Years, Middle Years and Diploma programmes, and is accredited by the New England Association of Schools and Colleges (NEASC) and the Council of International Schools (CIS). The International School of Turin (IST) is a non-proft and private coeducational, English- medium school offering programmes from the Early Years to Grade 12. The school was established in 1963 by a group of parents 43 and members of the foreign community residing in Turin. Their aim was to provide an international education for their children. The IST Community currently has 480 students enrolled, representing 43 different nationalities, with a teaching faculty comprised Students come from 43 different countries around the world of 65 members. IB DIPLOMA PROGRAMME IB COURSES IST DIPLOMA Three Higher & Standard Level Six subjects in any combination of Six IB or IST Subjects; Theory Curriculum Subjects; Theory of Knowledge; Higher or Standard Level; Theory of of Knowledge; Creativity, Action Students in the Primary School (EY - Grade Extended Essay; Creativity, Knowledge; Creativity, Action & Service; & Service; Research Project Action & Service Extended Essay/Research Project 5) follow the IB Primary Years Programme. The IB Middle Years Programme spans Environmental Systems & Societies. Online Grades 6-10. Italian nationals participate in Physical and Health Education Courses (Business and Management and the state Terza Media examination at the end Design Psychology) are also available. of Grade 8. The Secondary School culmina- Arts (Music, Visual Arts) Group 4 Experimental Sciences (HL & SL): tes with the IB Diploma Programme in grades Mathematics 11 and 12.
    [Show full text]
  • Mutational Profile of Malignant Pleural Mesothelioma
    cancers Article Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study Maria Pagano 1,*, Luca Giovanni Ceresoli 2, Paolo Andrea Zucali 3,4, Giulia Pasello 5, Marina Garassino 6, Federica Grosso 7, Marcello Tiseo 8,9 , Hector Soto Parra 10, Francesca Zanelli 1, Federico Cappuzzo 11, Francesco Grossi 12, Filippo De Marinis 13, Paolo Pedrazzoli 14,15 , Roberta Gnoni 1, Candida Bonelli 1, Federica Torricelli 16, Alessia Ciarrocchi 16 , Nicola Normanno 17 and Carmine Pinto 1 1 Oncology Unit, Clinical Cancer Centrer, Azienda Unità Sanitaria Locale (AUSL)-IRCCS di Reggio Emilia, 42121 Reggio Emilia, Italy; [email protected] (F.Z.); [email protected] (R.G.); [email protected] (C.B.); [email protected] (C.P.) 2 Medical Oncology, Cliniche Humanitas Gavazzeni, 42121 Bergamo, Italy; [email protected] 3 Department of Oncology, Humanitas Clinical and Research Center, IRCCS, 42557 Rozzano, Italy; [email protected] 4 Department of Biomedical Sciences, Humanitas University, 20090 Pieve Emanuele, Italy 5 Department of Oncology, Medical Oncology 2 Istituto Oncologico Veneto IRCCS, 35128 Padova, Italy; [email protected] 6 Department of Medical Oncology Fondazione IRCCS Istituto Nazionale dei Tumori, 20090 Milan, Italy; [email protected] 7 Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Mesothelioma and rare cancer unit, 15121 Alessandria, Italy; [email protected] 8 Department of Medicine and Surgery, University
    [Show full text]
  • Milan, February 5/7, 2020 1
    After the success of our first edition, we are pleased to announce MicrobiotaMI 2020: three days of scientific sessions and multidiscipli- nary networking at the brand new Humanitas Congress Center in Milan 5th-7th February 2020. Researchers in the broad field of microbiota, from bench to bedside, and companies will meet in Milano to share their knowledge and to Humanitas Congress Center create new collaborations and technology transfer opportunities. The program is divided into four core sessions: Humanitas Congress Center Milan, February 5/7, 2020 1. Gut-liver axis Milan, February 5/7, 2020 2. Gut-bone marrow axis 3. Mucosal microbiota in genito-urinary and respiratory systems Invited Speakers 4. Gut microbiota and the immune system: from allergies to cancer In each of these sessions, presentations will be made by leading immu- nologists and clinicians who will give keynote lectures on state of the Yasmine Belkaid Humanitas Congress Center art advancements in differing areas of the same microbiome field. A National Institute of Allergy and Infectious Diseases (NIAID), USA final round table for each session will discuss future development in Patrice D. Cani that area, encouraging contributions from the audience. Milan, February 5/7, 2020 Catholic University of Leuven, UCLouvain, Belgium Chairs: MicrobiotaMi is characterized by a multidisciplinary approach, an Ernst Holler outstanding scientific level, and a large active participation of young, N. Mancini, F. Peri, M. Rescigno University of Regensburg, Germany early stage researchers. We anticipate the attendance of researchers Iliyan Iliev Congress Venue from academia, clinical departments as well as biotech and pharma Weill Cornell Medicine, New York USA industries who are interested in the molecular, immunological and Humanitas Congress Center Alexander Khoruts translational aspects of microbiota.
    [Show full text]
  • Humanitas Research Hospital - Rozzano (MI)
    Innovation for Change 2017 01/02/2017 3 Humanitas Group 1 Humanitas Research Hospital - Rozzano (MI) 2 Humanitas San Pio X - Milan 3 Humanitas Medical Care - Arese (MI) 4 Humanitas Gavazzeni - Bergamo 5 Humanitas Mater Domini - Castellanza (VA) Humanitas Cellini - Turin 6 Humanitas Gradenigo - Turin Humanitas Catanese Oncology Center - 7 Catania 4 Humanitas Research Hospital Humanitas Research Hospital - founded in 1996 - is the leader of a group of 7 hospitals located in Milan, Bergamo, Turin, Castellanza and Catania. 5 Numbers 410M € ANNUAL REVENUES ANNUAL CLINICAL ACTIVITIES 40,000 inpatients, from all over Italy and abroad 2,3 M million medical examinations 2,500 PROFESSIONALS 56,000 emergency room +700 Doctors 2,9 M admissions million clinical analyses +300 Researchers 24,000 MRIs 49,000 CT scans +1,000 Nurses, technicians, biologists and other professionals +450 Staff and patient service providers 747 BEDS 75 in the medical, surgical and oncological day- hospital 90,000 SQM 28 in ICU ( intensive care unit) 75,000 sqm dedicated to clinical activities 154 in cardiopulmonary, orthopaedic and neuromotory rehabilitation oper 6,000 sqm dedicated to scientific activities 36 operating rooms 5,000 sqm dedicated to teaching 5 rooms dedicated to minimally invasive interventional cardiology +450 sqm dedicated to other reception +200 Visiting & surgical rooms facilities for patients and families 6 International Recognition Cited by Harvard Business Review as one of the most innovative hospitals worldwide. Harvard Business School Case study Prof.
    [Show full text]